Cameco shares rise as uranium sentiment improves and long-term contracting remains in focus

Cameco (CCJ) is up 4.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The move looks tied to a broader bid for uranium-linked equities as investors refocus on strengthening long-term uranium pricing/contracting signals and Cameco’s positioning as a large, liquid uranium supplier. This could also be supported by lingering optimism from recent contract wins and upbeat longer-term sell-side targets, even if there was no single company-specific headline driving the tape.

Details:

Industry long-term uranium pricing indicators moved higher into the end of Q1 2026, signaling stronger utility contracting activity and improving sentiment for producers.

Cameco disclosed a long-term uranium supply agreement with India’s Department of Atomic Energy, with an estimated contract value of about $2.6 billion on market-related pricing and deliveries slated for 2027–2035.

In its FY2025/Q4 results materials, Cameco highlighted improving year-over-year profitability metrics and reiterated its disciplined supply strategy amid rising long-term contracting activity.

Recent analyst actions included a raised price target while maintaining a positive rating, which can help reinforce momentum when sector sentiment turns risk-on.

Sources:

Cameco, TradeTech, GuruFocus

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

EARLY ACCESS

Receive CCJ Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$CCJ Hedge Fund Activity

We have seen 475 institutional investors add shares of $CCJ stock to their portfolio, and 415 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC removed 2,212,569 shares (-12.8%) from their portfolio in Q4 2025, for an estimated $202,427,937
FIL LTD removed 2,094,018 shares (-19.4%) from their portfolio in Q4 2025, for an estimated $191,581,706
CITIGROUP INC removed 1,781,746 shares (-71.4%) from their portfolio in Q4 2025, for an estimated $163,011,941
MARSHALL WACE, LLP added 1,729,454 shares (+7481.3%) to their portfolio in Q4 2025, for an estimated $158,227,746
ALLIANCEBERNSTEIN L.P. removed 1,638,428 shares (-46.6%) from their portfolio in Q4 2025, for an estimated $149,899,777
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. added 1,556,157 shares (+12.0%) to their portfolio in Q4 2025, for an estimated $142,372,803
MIZUHO MARKETS CAYMAN LP removed 1,530,760 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $140,049,232

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CCJ Congressional Stock Trading

Members of Congress have traded $CCJ stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CCJ stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 01/09, 12/24.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$CCJ Analyst Ratings

Wall Street analysts have issued reports on $CCJ in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

William Blair issued a "Outperform" rating on 04/20/2026
GLJ Research issued a "Buy" rating on 02/18/2026
RBC Capital issued a "Outperform" rating on 11/13/2025
Goldman Sachs issued a "Buy" rating on 10/29/2025

To track analyst ratings and price targets for $CCJ, check out Quiver Quantitative's $CCJ forecast page.

$CCJ Price Targets

Multiple analysts have issued price targets for $CCJ recently. We have seen 4 analysts offer price targets for $CCJ in the last 6 months, with a median target of $150.0.

Here are some recent targets:

Gordon L. Johnson from GLJ Research set a target price of $171.2 on 02/18/2026
Andrew D. Wong from RBC Capital set a target price of $160.0 on 02/17/2026
George Eadie from UBS set a target price of $140.0 on 11/10/2025
Brian Lee from Goldman Sachs set a target price of $109.0 on 10/29/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.